Company / Gross Margin
BioLife Solutions, Inc. Gross Margin History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
61.2%
FY2017
5-year range
-
FY2016-FY2017
Trend
+5.4%
vs FY2016
Sector context
#40 of 91
Health Care
What the data says
At 61.2%, BioLife Solutions, Inc.'s gross margin ranks #40 of 91 in the Health Care sector.
Based on SEC 10-K filings.
61.2% in FY2017.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#40 of 91 in Health CareTop 44% of 91This company 61.2% Sector average 53.8%
▼
+13.8% above sector average
Key checks
Key Insights
- In FY2017, gross margin increased 5.4% year-over-year.
- Currently 7.4pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | 61.2% | +5.4% |
| FY2016 | 58.1% | -1.8% |
As of FY2017 · SEC 10-K · Updated Feb 28, 2026